Citation Impact
Citing Papers
Phenotypic and functional features of human Th17 cells
2007 Standout
Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
2010 StandoutScience
The microbiota regulates type 2 immunity through RORγt + T cells
2015 StandoutScienceNobel
Flavivirus Replication Complex Assembly Revealed by DNAJC14 Functional Mapping
2012 StandoutNobel
An IL-17F/A Heterodimer Protein Is Produced by Mouse Th17 Cells and Induces Airway Neutrophil Recruitment
2007
Untangling the ErbB signalling network
2001 Standout
Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis
2000
The ErbB2 and ErbB3 receptors and their ligand, neuregulin-1, are essential for development of the sympathetic nervous system
1998
Target-conditioned diffusion generates potent TNFR superfamily antagonists and agonists
2024 StandoutScienceNobel
The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors
1999
Biochemical and Clinical Implications of the ErbB/HER Signaling Network of Growth Factor Receptors
1999
The EGF receptor family as targets for cancer therapy
2000
All ErbB Receptors Other Than the Epidermal Growth Factor Receptor Are Endocytosis Impaired
1996
ERbB-2 expression is rate-limiting for epidermal growth factor-mediated stimulation of ovarian cancer cell proliferation
2000
The homeobox gene Phox2b is essential for the development of autonomic neural crest derivatives
1999 StandoutNature
Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions.
1996
Growth regulation of human breast and ovarian tumor cells by heregulin: Evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness.
1996
Bivalence of EGF-like ligands drives the ErbB signaling network
1997
Signal transduction by epidermal growth factor and heregulin via the kinase-deficient ErbB3 protein
1998
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
An Acquired and Endogenous Glycocalyx Forms a Bidirectional “Don’t Eat” and “Don’t Eat Me” Barrier to Phagocytosis
2020 StandoutNobel
ErbB‐4 Activation Promotes Neurite Outgrowth in PC12 Cells
2000
Differential Roles of Interleukin-17A and -17F in Host Defense against Mucoepithelial Bacterial Infection and Allergic Responses
2009
The microbiota in adaptive immune homeostasis and disease
2016 StandoutNature
The Role of the Epidermal Growth Factor Receptor Family in Mammary Tumorigenesis and Metastasis
1999
Protein biosensors based on the principle of fluorescence resonance energy transfer for monitoring cellular dynamics
2006
Multifaceted roles for lipids in viral infection
2011
Signal integration by JNK and p38 MAPK pathways in cancer development
2009 Standout
ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling
1997
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
Cell Signaling by Receptor Tyrosine Kinases
2010 Standout
Binding specificities and affinities of egf domains for ErbB receptors
1999
Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers
1998
Analysis of Grb7 Recruitment by Heregulin-activated erbB Receptors Reveals a Novel Target Selectivity for erbB3
1998
The Structural Basis for the Specificity of Epidermal Growth Factor and Heregulin Binding
1995
Recognition of microorganisms and activation of the immune response
2007 StandoutNature
NF-κB, the first quarter-century: remarkable progress and outstanding questions
2012 Standout
The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands
1998
A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity
2008 StandoutNature
Crystal structure of the human 4-1BB/4-1BBL complex
2018
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types
1998
IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells
2007 StandoutNature
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
EGF–ERBB signalling: towards the systems level
2006 Standout
Neutrophil-Regulatory Tn Lymphocytes
2006
Selective Cleavage of the Heregulin Receptor ErbB-4 by Protein Kinase C Activation
1996
Fluorescence Resonance Energy Transfer Imaging Reveals that Chemokine-Binding Modulates Heterodimers of CXCR4 and CCR5 Receptors
2008
Novel mechanisms of RTK signal generation
1997
Dimerization of chemokine receptors in living cells: key to receptor function and novel targets for therapy
2008
The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer
2015
Interleukin-17 and Type 17 Helper T Cells
2009 Standout
Distinct roles for phosphoinositide 3-kinase, mitogen-activated protein kinase and p38 MAPK in mediating cell cycle progression of breast cancer cells
2002
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Tyrosine Phosphorylation and Proteolysis
1998
Targeting RAS signalling pathways in cancer therapy
2003 Standout
Epidermal Growth Factor-related Peptides Activate Distinct Subsets of ErbB Receptors and Differ in Their Biological Activities
1996
Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases
1997 Nature
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
The Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation
2008 Standout
HER4-mediated Biological and Biochemical Properties in NIH 3T3 Cells
1996
Epiregulin Is a Potent Pan-ErbB Ligand That Preferentially Activates Heterodimeric Receptor Complexes
1998
NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancer
2000 Standout
The mystery of membrane organization: composition, regulation and roles of lipid rafts
2017 Standout
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
2011 StandoutNobel
Lipids as modulators of membrane fusion mediated by viral fusion proteins
2007
The future of cancer treatment: immunomodulation, CARs and combination immunotherapy
2016
Cytokines in the pathogenesis of rheumatoid arthritis
2007 Standout
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
Structure and signalling in the IL-17 receptor family
2009 Standout
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function
2008 StandoutNature
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
Neutrophil recruitment and function in health and inflammation
2013 Standout
Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens
2008 Standout
New functions for the matrix metalloproteinases in cancer progression
2002 Standout
Cell Signaling by Receptor Tyrosine Kinases
2000 Standout
Neuregulin-1 and Human Epidermal Growth Factor Receptors 2 and 3 Play a Role in Human Lung Development In Vitro
2000
Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase
1999
Neuregulin-3 (NRG3): A novel neural tissue-enriched protein that binds and activates ErbB4
1997
Synthesis and Function of 3-Phosphorylated Inositol Lipids
2001 Standout
Isoform-specific expression and function of neuregulin
1997
Neu Differentiation Factor Activation of ErbB-3 and ErbB-4 Is Cell Specific and Displays a Differential Requirement for ErbB-2
1995
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging
2009 Standout
IL-17 and Th17 Cells
2009 Standout
IL-17 Family Cytokines and the Expanding Diversity of Effector T Cell Lineages
2007 Standout
Type 1 growth factor receptors: an overview of recent developments
1995
HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression
2001 StandoutNobel
The Cellular Response to Neuregulins Is Governed by Complex Interactions of the erbB Receptor Family
1995
ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer.
1996
The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand
2005
Antibody-modified T cells: CARs take the front seat for hematologic malignancies
2014
Phagocytosis: receptors, signal integration, and the cytoskeleton
2014
Characterization of a Neuregulin-Related Gene, Don-1, That Is Highly Expressed in Restricted Regions of the Cerebellum and Hippocampus
1997
Roles of Hoxa1 and Hoxa2 in patterning the early hindbrain of the mouse
2000 StandoutNobel
Going viral: chimeric antigen receptor T‐cell therapy for hematological malignancies
2014
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Neu differentiation factor/heregulin induction by hepatocyte and keratinocyte growth factors
2000
The P2X7 Receptor: A Key Player in IL-1 Processing and Release
2006
A Hierarchical Network of Interreceptor Interactions Determines Signal Transduction by Neu Differentiation Factor/Neuregulin and Epidermal Growth Factor
1996
ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2- and heregulin-deficient mice
1997
Cutting Edge: Interleukin 17 Signals through a Heteromeric Receptor Complex
2006
Requirement for Both JAK-Mediated PI3K Signaling and ACT1/TRAF6/TAK1-Dependent NF-κB Activation by IL-17A in Enhancing Cytokine Expression in Human Airway Epithelial Cells
2007
Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase
1995 StandoutScience
Regulation of Wound Healing by Growth Factors and Cytokines
2003 Standout
N‐Carboxyanhydride Polymerization of Glycopolypeptides That Activate Antigen‐Presenting Cells through Dectin‐1 and Dectin‐2
2018 StandoutNobel
Physiology of Microglia
2011 Standout
Transformation of NIH 3T3 Cells by HER3 or HER4 Receptors Requires the Presence of HER1 or HER2
1996
Works of Ling Yi being referenced
Genetic Modification of T Cells Redirected toward CS1 Enhances Eradication of Myeloma Cells
2014
TLR Signaling Paralyzes Monocyte Chemotaxis through Synergized Effects of p38 MAPK and Global Rap-1 Activation
2012
HIV gp120-induced Interaction between CD4 and CCR5 Requires Cholesterol-rich Microenvironments Revealed by Live Cell Fluorescence Resonance Energy Transfer Imaging
2006
Human and Mouse CD137 Have Predominantly Different Binding CRDs to Their Respective Ligands
2014
CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma
2013
Cutting Edge: Evidence for Ligand-Independent Multimerization of the IL-17 Receptor
2006
ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms.
1994
CD137‐CRDI is not necessary in the role of contacting its natural ligand
2016